Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
Author:
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
American Society of Transplant Surgeons
Publisher
Elsevier BV
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.17061
Reference30 articles.
1. COVID-19-associated mortality among kidney transplant recipients and candidates in the United States;Mohan;Clin J Am Soc Nephrol.,2021
2. Poor outcomes of COVID-19 in lung transplant recipients. Cohort study in a single center;Amor;J Heart Lung Transplant.,2021
3. COVID-19 in solid organ transplantation: results of the national COVID cohort collaborative;Vinson;Transplant Direct.,2021
4. Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients;Qin;Transplantation.,2021
5. Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses;Benotmane;JAMA.,2021
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE;Infectious Diseases and Therapy;2024-05-27
2. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients;Transplantation Reviews;2023-12
3. Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-Analysis Using GRADE;2023-08-13
4. Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial;Frontiers in Immunology;2023-08-01
5. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants;The Journal of Infectious Diseases;2023-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3